Neurologic symptoms improve in patients with Wilson's disease despite immunosuppression.
Schumacher
G
G
Department of General Surgery, Virchow Clinic, Humboldt University, Berlin, Germany.
Mueller
A R
AR
Platz
K P
KP
Neuhaus
R
R
Bechstein
W O
WO
Becker
M
M
Luck
W
W
Neuhaus
P
P
D000293:Adolescent; D000328:Adult; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006527:Hepatolenticular Degeneration / Q000503:physiopathology* / Q000628:therapy*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D009422:Nervous System Diseases / Q000209:etiology / Q000503:physiopathology*; D011183:Postoperative Complications; D011239:Prednisolone / Q000627:therapeutic use*; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D016559:Tacrolimus